HOME FACULTY RESEARCH NEWS EN | ES LOGIN

placeholder image

Email

carlosjerjes@tec.mx

Campus

Campus Monterrey, Institute for Obesity Research
Adjunct researcher, Experimental Medicine and Advanced Therapies , Institute for Obesity Research

Cardiology
Cardiology
Lung diseases
Lung diseases
Medicine

Co-author Network

Sánchez-Díaz, Carlos Jerjes

Overview

No overview

Overview
Publications
Teaching
Background
Contact
Other
View All

Overview

authors

Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes
Sánchez-Díaz, Carlos Jerjes

Publications

selected publications

academic article in scopus
- Distinctions between survivors and non-survivors with SARS-CoV-2 vaccine-induced thrombotic thrombocytopenia: A systematic review and meta-analysis. Vaccine: X. 2023
- Soluble factors in COVID-19 mRNA vaccine-induced myocarditis causes cardiomyoblast hypertrophy and cell injury: a case report. Virology Journal. 2023
- ¿Pulmonary embolism response teams: changing the paradigm in the care for acute pulmonary embolism¿: reply. Journal of Thrombosis and Haemostasis. 21:1390-1392. 2023
- Editorial: Pulmonary embolism¿New diagnostic and therapeutic strategies. Frontiers in Medicine. 2023
- Risk Factors, Clinical Presentation, Therapeutic Trends, and Outcomes in Arterial Thrombosis Complicating Unvaccinated COVID-19 Patients: A Systematic Review. Angiology. 2023
- Unexpected arterial thrombosis and acute limb ischemia in COVID-19 patients. Results from the Ibero-Latin American acute arterial thrombosis registry in COVID-19: (ARTICO-19). Vascular. 30:1107-1114. 2022
- Riociguat in the Treatment of Pulmonary Arterial Hypertension. Archives of Medical Research. 53:352-358. 2022
- Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension. Respiratory Medicine. 193. 2022
- Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism. Journal of Thrombosis and Haemostasis. 20:2457-2464. 2022
- Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review. Thrombosis Journal. 19. 2021
- Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening. American Journal of Medicine. 134:893-901.e11. 2021
- Clinical outcomes of very elderly patients treated with ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: a systematic review. Journal of Thrombosis and Thrombolysis. 52:260-271. 2021
- Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction. Oxidative Medicine and Cellular Longevity. 2021. 2021
- GARFIELD-AF: A worldwide prospective registry of patients with atrial fibrillation at risk of stroke. Future Cardiology. 17:19-38. 2021
- Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension. Oxidative Medicine and Cellular Longevity. 2021. 2021
- Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012. PLoS ONE. 15. 2020
- Systemic thrombolysis and anticoagulation improved biomarker measurements in massive-like pulmonary embolism and severe COVID-19 pneumonia: A case report. European Heart Journal - Case Reports. 4. 2020
- Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review. Journal of Thrombosis and Thrombolysis. 50:929-941. 2020
- Severe covid-19 disease and thromboinflammation Enfermedad grave covid-19 y tromboinflamación. Archivos de Cardiologia de Mexico. 90:257-258. 2020
- Percutaneous placement of intra-aortic balloon pump in the left axillary position improving quality of care in severe heart failure Colocación percutánea de balón de contrapulsación intraaórtico para mejorar la calidad de cuidado en falla cardiaca grave. Archivos de Cardiologia de Mexico. 90:539-541. 2020
- Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature. Oxidative Medicine and Cellular Longevity. 2020. 2020
- The hospital zambrano hellion venous thromboembolism rapid response team (PREVENTION-team): Improving pulmonary embolism and deep venous thrombosis patient care Equipo de respuesta rápida para tromboembolismo venoso del hospital zambrano hellion (PREVENTION-team): mejorando el manejo del tromboembolismo pulmonar y trombosis venosa profunda. Archivos de Cardiologia de Mexico. 90:28-38. 2020
- Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure. Oxidative Medicine and Cellular Longevity. 2020. 2020
- Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry. Clinical Cardiology. 42:553-560. 2019
- Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: Study protocol. BMJ Open. 9. 2019
- PubTerm: A web tool for organizing, annotating and curating genes, diseases, molecules and other concepts from PubMed records. Database : the journal of biological databases and curation. 2019. 2019
- Polymorphisms -455G/A and -148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events. Disease Markers. 2019. 2019
- B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: A prospective, multicentre, cross-sectional study. BMJ Open. 8. 2018
- Factor Xa inhibition and sPESI failure in intermediate-high-risk pulmonary embolism. American Journal of Emergency Medicine. 36:1925.e3-1925.e4. 2018
- The use of cardiac CT as a roadmap for resolving coronary stent dislodgement El uso de TC cardiaca como Guía para resolución de un stent coronario dislocado. Archivos de Cardiologia de Mexico. 88:318-319. 2018
- Giant coronary ectasia and athlete¿s heart mimicking an acute coronary syndrome Ectasia coronaria gigante y corazón de atleta que simulan un síndrome coronario agudo. Archivos de Cardiologia de Mexico. 88:228-229. 2018
- Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. Journal of Thrombosis and Thrombolysis. 44:377-385. 2017
- A systematic review of genetic mutations in pulmonary arterial hypertension. BMC Medical Genetics. 18. 2017
- Inferior vena cava filters in pulmonary embolism: A historic controversy Filtros de vena cava inferior en tromboembolia pulmonar: Una controversia histórica. Archivos de Cardiologia de Mexico. 87:155-166. 2017
- Mexican registry of pulmonary hypertension REMEHIP Registro Mexicano de hipertensión pulmonar REMEHIP. Archivos de Cardiologia de Mexico. 87:13-17. 2017
- Intermediate- to high-risk pulmonary embolism with normal B-type natriuretic peptide. American Journal of Emergency Medicine. 34:2463.e1-2463.e3. 2016
- Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The third national registry of acute coronary syndromes (RENASICA III) Abordaje clínico y evolución hospitalaria en pacientes mexicanos con sindrome coronario agudo: El Tercer Registro Nacional de Síndromes Coronarios Agudos (RENASICA III). Archivos de Cardiologia de Mexico. 86:221-232. 2016
- Ischaemic stroke from a large mitral vegetation as clinical presentation of infective endocarditis. European Heart Journal Cardiovascular Imaging. 17:522. 2016
- The role of a multimodality imaging approach in diagnosis and stratification of aborted sudden cardiac death. Canadian Journal of Cardiology. 31:103.e9-103.e11. 2015
- Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus. Lupus. 23:935-938. 2014
book in scopus

Teaching

teaching activities

Cardiology
Elective Specialty
Medical Care in Cardiology
Research Seminar

Background

awards and honors

Mexican Researcher Certification - Level 3 (Sánchez-Díaz, Carlos Jerjes)

Contact

full name

Carlos Jerjes Sánchez Díaz

located in facility

Campus Monterrey

webpage

LinkedIn
Orcid
ResearchGate

Other

Expertise ODS

Good health and well-being ODS

HOME | FACULTY | RESEARCH | NEWS

© ITESM. All rights reserved.